Skip to content
Screener

Adaptive Biotechnologies ADPT Q4 2025 Annual earnings

Reported February 5, 2026 · After market close

Revenue$71.7MBeat by $10.8M
EPS-$0.09Beat by $0.10
Revenue estimate$60.9M
EPS estimate-$0.19

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$71.6M
EPS estimate-$0.10

Financials

Q4 2025

Income statement

See full
Revenue$71.7M+51.0%
Gross profit$53.5M+81.7%
Operating income-$12.8M+62.3%
Net income-$13.6M+59.7%
EPS (diluted)-$0.09+59.1%

Balance sheet

See full
Cash & equivalents$70.5M+47.1%
Total debt$210.4M-5.5%
Total equity$218.8M+7.9%
Total assets$512.7M-4.9%

Cash flow

See full
Operating cash flow-+100%
CapEx$636.0K+695%
Free cash flow-+100%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$2.48B+180%
Enterprise value$2.62B+147%
P/S9×+4.0×

Profitability

See full
Gross margin74.2%+14.5pp
Operating margin-20.6%-9.0pp
Net margin-21.5%-9.3pp
FCF margin-18.2%-7.3pp

Returns & leverage

See full
Return on equity-28.2%-10.0pp
Debt / equity1×-0.1×
Current ratio3.3×+0.4×

Segments

By product

See full
Service$58.9M+46.7%
Service And Licensing Revenue$5.8M+16.9%
Regulatory Milestone Revenue$3.0M—
Collaboration Revenue--100%

By segment

See full
Mrd Business$61.9M+54.1%
Immune Medicine Business$9.8M+34.0%

FAQ

When did Adaptive Biotechnologies report Q4 2025 earnings?
Adaptive Biotechnologies (ADPT) reported Q4 2025 earnings on February 5, 2026 after market close.
What were Adaptive Biotechnologies's Q4 2025 revenue and EPS?
Adaptive Biotechnologies reported revenue of $71.7M and eps of $-0.09 for Q4 2025.
Did Adaptive Biotechnologies beat estimates in Q4 2025?
Revenue beat the consensus estimate of $60.9M by $10.8M. EPS beat the consensus estimate of $-0.19 by $0.10.
How did Adaptive Biotechnologies's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 51.0% from $47.5M a year earlier and eps grew 60.9% from $-0.23.
Where can I find Adaptive Biotechnologies's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-039409) and the 10-K periodic report (0001193125-26-076902) directly on SEC EDGAR. The filing index links above go to sec.gov.